Stock Market News for September 1, 2026

Cybersecurity, AI and enterprise security

CrowdStrike (CRWD) remains center stage with multiple strategic moves. In addition to commercial wins and product launches earlier today, CrowdStrike extended Falcon platform capabilities across Google Cloud’s Enterprise AI ecosystem, deepening cloud partnerships that can accelerate adoption of its AI‑driven detection stack and potentially increase recurring security revenue.

Rubrik (RBRK) teamed up with CrowdStrike to bring agentic automation to identity attack resilience, which could shrink detection‑to‑remediation windows and raise enterprise switching costs for incident response tooling.

Palo Alto Networks (PANW) added to sector momentum with its Console acquisition to "agentify" security, and reported fiscal Q4 and FY2026 results investors will parse for signs of enterprise spend resilience amid macro pressure.

AI infrastructure and data centers

Cerebras (CBRS) and Compute Nordic continue planning a 165 MW AI data center in Finland, underscoring hyperscale demand for integrated chip‑to‑facility partnerships in Europe.

Energy Vault (NRGV) received Italian government designation for its 100 MW AI infrastructure project in Sardinia, a permitting boost that can speed grid integration for energy‑dense AI sites.

Bitdeer (BTDR) bought 200 acres near its Rockdale facility in Texas to support AI/HPC growth, a concrete land‑bank move as colocation competition intensifies.

Semiconductors, vision AI and robotics M&A

Navitas (NVTS) shipped Gen‑5 GaNFast™ made at GlobalFoundries (release), a modest efficiency advance that matters for server and GPU power delivery as AI racks scale.

ROC (ROC) closed its acquisition of ZTC (notice), strengthening its vision‑AI offering, while XTEND (JFB) launched the AtlasROVER to expand into ground vehicles (product release), both broadening autonomy addressable markets.

Software, cloud and earnings that move markets

Dell Technologies (DELL) delivered Q2 FY2027 results, watched as a bellwether for server and AI infrastructure spend.

MongoDB (MDB) reported Q2 FY2027 financials, feeding the narrative on cloud migration and developer platform monetization.

GitLab (GTLB) also released Q2 FY2027 results, with subscription growth and margin trends in focus for DevOps investors.

Credo Technology Group (CRDO) posted Q1 FY2027 results, relevant to connectivity and custom chip demand themes.

Autos, EV charging and energy-in-use milestones

NIO (NIO) posted unaudited Q2 2026 results; delivery cadence and margin recovery remain focal points for China EV names.

ChargePoint (CHPT) appointed John Saffrett to lead European expansion (hire), a strategic push for charger network densification.

Xos (XOS) said its Xos Hub has surpassed one gigawatt‑hour of energy delivered in the field (milestone), a data point for fleet electrification adoption and product reliability.

Retail transactions and corporate cleanups

Red Robin (RRGB) completed the sale of 108 restaurants for $89.4 million, reshaping the portfolio and improving cash flow flexibility.

Chegg (CHGG) announced full repayment of convertible notes, removing a financing overhang and simplifying its capital structure ahead of strategic choices.

Capital moves, crypto exposure and financing updates

Hyperscale Data (GPUS) updated investors: the firm sold about 65 BTC in the week ended Aug. 30 and holds roughly 215 BTC (treasury update), and separately highlighted that second‑quarter other revenue—largely blockchain‑related—increased 647% (revenue note), underlining how crypto and enterprise blockchain are reshaping its top‑line volatility.

Reitar Logtech (RITR) eliminated all outstanding convertible notes (notice), simplifying its cap table before growth execution.

Biotech & medtech: trials, regulatory timing and commercial progress

Ultragenyx (RARE) published a successful 96‑week randomized, placebo‑controlled trial with crossover of GENGLYCOS™ (DTX401) AAV gene therapy in GSDIa in The Journal of Inherited Metabolic Disease (publication), a strong signal for long‑term efficacy in a rare‑disease program.

Upstream Bio (UPB) announced pivotal Phase 3 plans for verekitug in severe asthma and CRSwNP (development update), a program that could be material to future revenue if late‑stage data are positive.

BillionToOne (BLLN) launched Northstar Origin, expanding liquid biopsy capabilities into tissue‑of‑origin detection—an advance for oncology diagnostics workflows.

aTyr Pharma (ATYR) provided an update on timing of a regulatory response for its planned Phase 3 study of efzofitimod in pulmonary sarcoidosis (regulatory timing), a cadence detail investors will watch for program de‑risking and trial initiation timelines.

Selected commercial wins and partnerships

• Fervo Energy (FRVO) signed a 396 MW PPA with Google, reinforcing corporate demand for firm low‑carbon power that supports project economics.

Patent, IP and space‑tied technology wins

AEye (LIDR) said its Apollo™ lidar was chosen for Lunar Outpost’s Pegasus lunar terrain vehicle (selection), opening a niche sensing opportunity tied to space operations.

Lightbridge (LTBR) received a notice of allowance for a Japanese patent on a multi‑zone fuel element and 3D printing method (patent update), relevant to advanced reactor licensing discussions.

Local market notices, bids and housekeeping

Yatra Online (YTRA) said its board unanimously rejected Magna Holdings’ unsolicited partial tender offer (statement), an outcome that preserves the company's existing strategy and may influence next steps in shareholder engagement.

NuRAN Wireless (NUR) announced plans to voluntarily delist from the Canadian Securities Exchange (notice), a move that can affect liquidity for retail investors and secondary market access.

Several smaller filings—inducement grants and conference participations—were submitted today but were deprioritized to keep focus on earnings, major M&A, infrastructure and regulatory developments that drive market outlooks.